This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

EMDR in the Treatment of Specific Phobia.

This study has been withdrawn prior to enrollment.
(approval of ethical committee was denied)
Sponsor:
Collaborator:
St. Olavs Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00184145
First received: September 10, 2005
Last updated: February 24, 2017
Last verified: February 2017
  Purpose
The purpose for this study is to determine whether EMDR is effective in the treatment of specific (animal) phobia.

Condition Intervention
Specific Phobia Other: EMDR (Eye Movement Desensitization and Reprocessing) Other: Exposure therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: EMDR (Eye Movement Desensitization and Reprocessing) in the Treatment of Specific Phobia. A Randomised Controlled Trial.

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Behavioral Approach Test towards the feared animal. [ Time Frame: Before and after each treatment ]

Secondary Outcome Measures:
  • Scores on self-report questionnaires on phobic symptoms [ Time Frame: Before and after both treatments ]
  • Neuropsychological function [ Time Frame: Before first treatment, some measures also before second treatment ]
  • Cognitive strategies [ Time Frame: Before both treatments ]

Enrollment: 0
Actual Study Start Date: June 2004
Study Completion Date: September 2004
Primary Completion Date: September 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: EMDR
The experimental group was treated for animal phobia by EMDR, control group received an attention placebo (relaxation plus breathing exercises). Afterwards, both groups were treated by exposure therapy (therapy of choice for animal phobia).
Other: EMDR (Eye Movement Desensitization and Reprocessing)
Psychotherapy which is approved for PTSD.
Other: Exposure therapy
All participants in the study received exposure therapy som second treatment. Exposure therapy is the therapy of choice for animal phobia.

Detailed Description:
Aims: To test the hypothesis that one session EMDR is more effective for the treatment of specific (animal) phobia than relaxation immediately after treatment and at follow-up. Secondly to test whether an additional one-session exposure therapy offered to both treatment groups (EMDR patients and relaxation patients) improves outcome in the EMDR-group and results in equal outcome for both treatment groups.
  Eligibility

Ages Eligible for Study:   15 Years to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with Specific (Animal) Phobia

Exclusion Criteria:

  • Current or past psychotic disorder
  • Current substance dependence or abuse
  • Serious physical illness
  • Active suicidal behavior
  • Bipolar affective disorder
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00184145

Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Investigators
Principal Investigator: Ludger Kaiser, Doctor
  More Information

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184145     History of Changes
Other Study ID Numbers: EPLK-2004
Study First Received: September 10, 2005
Last Updated: February 24, 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Norwegian University of Science and Technology:
Specific (Animal) Phobia
EMDR
Exposure therapy

Additional relevant MeSH terms:
Phobic Disorders
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 23, 2017